dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline combining with GLP-1 receptor agonists Frontiers Neuroprotection by dipeptidyl-peptidase-4 inhibitors and

CJC1295 stimulates GH secretion and increases IGF1 levels without significantly elevating prolactin or cortisol, making it favorable for long-term use. Walker, Frontiers in Endocrinology How CJC1295 Works CJC1295 functions by stimulating the pituitary gland to release more growth hormone (GH)

Additionally, GHRP-2 may have caused a significant decrease, by about 92%, in the aortic gene expression of 12/15-lipoxygenase

Regan isoenzyme and hCG in ovarian oncology research models [PMID: 1234637] Laboratory literature summary: Regan isoenzyme and hCG in ovarian oncology research models

That said, it always pays to err on the side of caution and I wouldn't use out of date ones in somebody else, unless I had no option

Cell Mol Life Sci

To the best of the co-authors' knowledge, author Ze'ev Hochberg fulfils the authorship criteria in line with Frontiers policy